InfuSystem Holdings Inc

Research InfuSystem Holdings Inc (INFU) on Bullrun: market cap USD 239.37M, P/E 29.5. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 239.37M; P/E is 29.5.

Peer valuation comparison

Latest P/E is 29.5x versus a Healthcare sector median of 24.46x (20.6% above).

Latest P/E is 29.5x versus a United States median of 24.87x (18.6% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 143.44MUSD 6.63MUSD 23.85M56.0%0.31USD 3.19MUSD 19.63MUSD 57.33M
FY2024USD 134.86MUSD 2.35MUSD 19.37M52.2%0.11USD 527.00KUSD 23.86MUSD 57.53M
FY2023USD 125.79MUSD 872.00KUSD 10.20M50.2%0.04USD 231.00KUSD 29.10MUSD 52.30M
FY2022USD 109.91MUSD 18.00KUSD 16.54M55.1%0USD 165.00KUSD 33.16MUSD 48.00M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 239.37M29.5n/an/a
20252025-12-31USD 181.28M28.0n/an/a
20242024-12-31USD 179.75M76.8n/an/a
20232023-12-29USD 223.27M263.5n/an/a
20222022-12-30USD 179.30M868.0n/an/a
20212021-12-31USD 352.51M283.8n/an/a

About InfuSystem Holdings Inc

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is InfuSystem Holdings Inc's market cap?

InfuSystem Holdings Inc's market capitalization is USD 239.37M.

What is InfuSystem Holdings Inc's P/E ratio?

InfuSystem Holdings Inc's price-to-earnings (P/E) ratio is 29.5.

What does InfuSystem Holdings Inc do?

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.